Two Sigma Investments LP lifted its position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 143.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 147,486 shares of the company's stock after buying an additional 86,974 shares during the quarter. Two Sigma Investments LP owned about 0.45% of Bowhead Specialty worth $5,239,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the business. Summit Investment Advisors Inc. increased its position in Bowhead Specialty by 66.4% during the 4th quarter. Summit Investment Advisors Inc. now owns 1,218 shares of the company's stock worth $43,000 after purchasing an additional 486 shares in the last quarter. New York State Common Retirement Fund acquired a new position in shares of Bowhead Specialty during the fourth quarter worth $64,000. US Bancorp DE bought a new position in shares of Bowhead Specialty in the 4th quarter valued at $76,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Bowhead Specialty during the 4th quarter valued at $107,000. Finally, Pictet Asset Management Holding SA bought a new stake in Bowhead Specialty during the 4th quarter worth $145,000.
Analyst Upgrades and Downgrades
A number of analysts recently weighed in on BOW shares. Morgan Stanley increased their price objective on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a report on Monday, May 19th. Keefe, Bruyette & Woods upped their target price on Bowhead Specialty from $43.00 to $45.00 and gave the company an "outperform" rating in a report on Friday, May 9th. Piper Sandler began coverage on shares of Bowhead Specialty in a research report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price target on the stock. JPMorgan Chase & Co. lifted their target price on shares of Bowhead Specialty from $30.00 to $35.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 8th. Finally, JMP Securities boosted their target price on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $39.67.
View Our Latest Report on Bowhead Specialty
Bowhead Specialty Trading Up 0.3%
NYSE BOW traded up $0.13 on Friday, hitting $37.29. The company's stock had a trading volume of 152,033 shares, compared to its average volume of 199,733. The firm has a market cap of $1.22 billion and a P/E ratio of 28.47. Bowhead Specialty Holdings Inc. has a 52-week low of $23.70 and a 52-week high of $42.29. The company's 50-day simple moving average is $39.22 and its 200 day simple moving average is $35.98.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.01. The company had revenue of $174.85 million for the quarter, compared to the consensus estimate of $105.17 million. On average, research analysts forecast that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.